GlassScriptPhysician profile
Charles C Cummings
NPI 1881697233
$114,355.41
in general payments reported to CMS, 2019-2025
55 companies · $3,482 in 2025
The $3,482 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $8,527 · 2021: $8,250 · 2022: $13K · 2023: $14K · 2024: $5,761 · 2025: $3,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $9,624 · Consulting Fee: $1,200 · Royalty Or License: $0.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,499.50 |
| Food and Beverage | $9,624.30 |
| Consulting Fee | $1,200.00 |
| Royalty Or License | $0.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $35,716.83 | 2019-2025 | Eliquis, Camzyos |
| Pfizer INC. | $19,080.72 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $18,216.87 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $11,277.70 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $10,348.20 | 2019-2024 | Evkeeza |
| Astrazeneca Pharmaceuticals LP | $3,953.11 | 2019-2025 | Farxiga |
| Boston Scientific Corporation | $3,390.55 | 2019-2025 | Avvigo Guidance System, General - Crm_crm, Synergy |
| Abbott Laboratories | $3,337.96 | 2019-2025 | Dragonfly Opstar, Xience Skypoint, Optis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $932.51 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $767.17 | 2019-2024 | Xarelto |
| Medtronic, INC. | $747.26 | 2021-2024 | Linq II, Telescope |
| Novo Nordisk INC | $723.61 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $571.16 | 2019-2025 | Jardiance |
| Edwards Lifesciences Corporation | $556.16 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $487.21 | 2019-2025 | Repatha, Repatha |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $416.41 | 2019-2025 | Impella |
| Merck Sharp & Dohme LLC | $365.82 | 2021-2025 | Verquvo, Capvaxive |
| Esperion Therapeutics, INC. | $325.01 | 2020-2021 | |
| Biotronik INC. | $281.47 | 2019-2022 | |
| Chiesi USA, INC. | $254.93 | 2020-2022 | |
| Kestra Medical Technology Services, INC. | $254.09 | 2023-2025 | Assure Wcd |
| Heartflow, INC. | $235.02 | 2025 | |
| Irhythm Technologies, INC. | $233.21 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Atricure, INC. | $227.93 | 2022-2025 | Atriclip Laa Exclusion System |
| Inari Medical, INC. | $188.87 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $147.99 | 2022 | |
| Cvrx, INC. | $138.05 | 2025 | Barostim Neo System |
| Amarin Pharma, INC. | $122.84 | 2019-2022 | |
| Terumo Medical Corporation | $100.56 | 2023-2025 | Angio-Seal, Glidewire, Tr Band |
| Philips North America LLC | $95.07 | 2024-2025 | (6585) Omniwire, (6572) Rotational, Ambulatory Monitoring & Diagnostics Undivided |
| Bardy Diagnostics, INC. | $84.83 | 2020-2022 | |
| Scpharmaceuticals INC. | $79.37 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $73.43 | 2023-2024 | Onpattro |
| Lundbeck LLC | $56.72 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $56.36 | 2024 | Arcalyst |
| Preventice Services, LLC | $46.55 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $46.33 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.40 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $39.37 | 2024 | Opsumit |
| Bridgebio Pharma, INC. | $38.77 | 2025 | Attruby |
| Teleflex LLC | $37.91 | 2025 | Turnpike, Vascband |
| Glaxosmithkline, LLC. | $35.67 | 2025 | Shingrix, Arexvy |
| Kiniksa Pharmaceuticals, LTD. | $29.13 | 2021 | |
| Getinge USA Sales, LLC | $28.60 | 2020 | |
| Medtronic Vascular, INC. | $23.05 | 2019 | |
| Baxter Healthcare | $20.81 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Cook Medical LLC | $18.75 | 2022 | |
| Medicomp INC | $18.10 | 2024 | Telepatch Cardiac Monitor |
| Ge Healthcare | $16.50 | 2019 | |
| Gilead Sciences, INC. | $16.34 | 2019 | |
| Inspire Medical Systems, INC. | $14.27 | 2024 | Inspire |
| Itamar Medical INC | $14.26 | 2024 | Watchpatone |
| Cardiva Medical, INC. | $14.02 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Arbor Pharmaceuticals, INC. | $12.58 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Cummings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.